The_DT
catalytic_JJ
domain_NN
of_IN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
,_,
but_CC
not_RB
its_PRP$
regulatory_JJ
domain_NN
,_,
is_VBZ
sufficient_JJ
for_IN
inducing_VBG
IL-2_NN
production_NN
._.

The_DT
lymphoid_JJ
src_NN
kinase_NN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
has_VBZ
been_VBN
shown_VBN
to_TO
be_VB
essential_JJ
for_IN
the_DT
induction_NN
of_IN
different_JJ
T_NN
lymphocyte_NN
responses_NNS
,_,
including_VBG
CD4-mediated_JJ
enhancement_NN
of_IN
Ag-induced_JJ
T_NN
cell_NN
activation_NN
,_,
early_JJ
T_NN
cell_NN
differentiation_NN
,_,
induction_NN
of_IN
IL-2_NN
production_NN
,_,
and_CC
cytotoxicity_NN
._.

It_PRP
is_VBZ
assumed_VBN
that_IN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
acts_VBZ
on_IN
these_DT
processes_NNS
by_IN
phosphorylating_VBG
substrates_NNS
._.

However_RB
,_,
it_PRP
has_VBZ
been_VBN
recently_RB
reported_VBN
that_IN
the_DT
NH2_NN
regulatory_JJ
domain_NN
is_VBZ
sufficient_JJ
to_TO
mediate_VB
CD4_NN
accessory_NN
function_NN
._.

In_IN
this_DT
report_NN
we_PRP
address_VBP
the_DT
contribution_NN
of_IN
the_DT
regulatory_JJ
and_CC
catalytic_JJ
domains_NNS
of_IN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
to_TO
another_DT
function_NN
of_IN
this_DT
enzyme_NN
independent_JJ
of_IN
CD4_NN
:_:
TCR-induced_JJ
IL-2_NN
production_NN
._.

Two_CD
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
mutants_NNS
lacking_VBG
either_CC
the_DT
entire_JJ
catalytic_JJ
domain_NN
or_CC
the_DT
entire_JJ
NH2_NN
regulatory_JJ
domain_NN
were_VBD
generated_VBN
,_,
and_CC
their_PRP$
abilities_NNS
to_TO
trigger_VB
transactivation_NN
of_IN
the_DT
TCR-regulated_JJ
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
region_NN
of_IN
the_DT
IL-2_NN
promoter_NN
were_VBD
compared_VBN
._.

Only_RB
the_DT
catalytic_JJ
,_,
but_CC
not_RB
the_DT
NH2_NN
regulatory_JJ
,_,
domain_NN
of_IN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
was_VBD
able_JJ
to_TO
induce_VB
NF-AT_NN
region_NN
transactivation_NN
on_IN
its_PRP$
own_JJ
and_CC
to_TO
cooperate_VB
with_IN
other_JJ
intracellular_JJ
signals_NNS
to_TO
trigger_VB
this_DT
response_NN
._.

Moreover_RB
,_,
the_DT
catalytic_JJ
domain_NN
of_IN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
was_VBD
able_JJ
to_TO
induce_VB
IL-2_NN
cytokine_NN
production_NN
to_TO
an_DT
extent_NN
similar_JJ
to_TO
that_DT
of_IN
wild-type_JJ
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
._.

We_PRP
conclude_VBP
that_IN
different_JJ
domains_NNS
of_IN
the_DT
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
molecule_NN
contribute_VBP
to_TO
regulate_VB
distinct_JJ
biologic_JJ
functions_NNS
._.

In_IN
fact_NN
,_,
while_IN
the_DT
NH2_NN
regulatory_JJ
domain_NN
is_VBZ
sufficient_JJ
to_TO
mediate_VB
CD4_NN
accessory_NN
function_NN
,_,
we_PRP
show_VBP
here_RB
that_IN
the_DT
catalytic_JJ
domain_NN
of_IN
pp56_NN
-LRB-_-LRB-
lck_NN
-RRB-_-RRB-
is_VBZ
sufficient_JJ
for_IN
induction_NN
of_IN
IL-2_NN
production_NN
,_,
mimicking_VBG
TCR_NN
ligation_NN
._.

